Skip to main content
. 2017 Sep 27;2017(9):CD011469. doi: 10.1002/14651858.CD011469.pub2

NCT02370719.

Trial name or title Evaluation of an mHealth behavioural intervention for the self‐management for type 2 diabetes
Methods Type of study: efficacy study
Allocation: randomised
Intervention model: parallel assignment
Masking: open label
Primary purpose: treatment
Participants Condition: type 2 diabetes, emotional distress, stress
Enrollment: 150
Inclusion criteria:
  • English‐speaking individuals

  • Diagnosed with non‐insulin requiring type 2 diabetes

  • Outpatients

  • Baseline A1c of 7.5% or higher


Exclusion criteria:
  • Patients who are deemed unable to use a mobile phone (e.g. due to vision problems), and/or to comply with home monitoring (e.g. suffering from anxiety or depression)

  • Diabetes duration < 1 year

Interventions Intervention(s): mobile application for diabetes self‐management
Comparator(s): standard of care
Outcomes Timepoint(s): baseline, 3, 6, 9 and 12 months
Primary outcome(s):
  • HbA1c


Secondary outcome(s):
  • Blood pressure

  • Weight

  • Cholesterol (LDL and total)

  • Medication changes

  • Glycaemic excursions

  • BMI

  • DDS

  • Diabetes Empowerment Scale

  • Summary of Diabetes Self‐Care Activities


Other outcome(s): —
Starting date Trial start date: June 2015
Trial completion date: July 2017
Contact information Responsible party/principal investigator: University Health Network, Toronto, Canada/Joseph A Cafazzo
Study identifier NCT number: NCT02370719
Official title Evaluation of an mHealth behavioural intervention for the self‐management for type 2 diabetes mellitus
Stated purpose of study Quote: "The purpose of this study is to evaluate a patient‐centered diabetes self‐management mobile application (app), which was developed with feedback from both patients and healthcare providers. During the 12 month participants in the intervention group will be provided with a mobile phone and commercial home medical devices, such as a weight scale, glucometer and activity monitor. The measurements taken from the medical devices will wirelessly transfer to the mobile phone, where the app will assess the data and provide patients with actionable self‐management knowledge."
Notes This study is currently recruiting participants. Contact: Shivani Goyal, sgoyal@ehealhinnovation.org